112 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
, Agios is poised for significant near- and long-term growth as we progress toward of our vision of becoming a leading rare disease company.”
Fourth
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
Improves overall red blood cell health PKM2 Improvement of hemolytic anemia Early and sustained response Potential long term benefits Consistent
8-K
EX-99.1
r6b2wi qe7b3mglinco
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
EX-99.1
6w06c oadi2fbj461vp
12 Jul 22
Agios Appoints Brian Goff as Chief Executive Officer
4:14pm
8-K
EX-99.1
66snvhv6
5 May 22
Agios Reports Business Highlights and First Quarter 2022 Financial Results
7:21am
8-K
EX-99.1
3e2u2
24 Feb 22
Agios Reports Fourth Quarter and Full Year 2021 Financial Results
7:40am
8-K
EX-99.1
ygw7tgw4kr
3 Nov 21
Agios Reports Business Highlights and Third Quarter 2021 Financial Results
7:27am